Spectral AI (NASDAQ:MDAI) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Spectral AI (NASDAQ:MDAI) posted its quarterly earnings results on Tuesday. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.05), Zacks reports. Spectral AI updated its FY 2025 guidance to EPS.

Spectral AI Stock Performance

Shares of NASDAQ MDAI traded down $0.10 during trading hours on Tuesday, hitting $1.72. The stock had a trading volume of 809,071 shares, compared to its average volume of 546,112. The firm’s 50-day moving average price is $2.17 and its two-hundred day moving average price is $2.09. Spectral AI has a 52 week low of $1.01 and a 52 week high of $3.25. The company has a market capitalization of $52.79 million, a P/E ratio of -2.49 and a beta of 0.91.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Spectral AI in a report on Friday, October 31st. Wall Street Zen downgraded shares of Spectral AI from a “hold” rating to a “strong sell” rating in a research report on Saturday, August 16th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Spectral AI has a consensus rating of “Hold” and a consensus price target of $3.50.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC acquired a new position in Spectral AI during the 2nd quarter worth $74,000. Marshall Wace LLP acquired a new stake in shares of Spectral AI in the second quarter valued at about $104,000. XTX Topco Ltd bought a new position in shares of Spectral AI in the second quarter worth about $123,000. Finally, Geode Capital Management LLC increased its stake in shares of Spectral AI by 21.8% in the second quarter. Geode Capital Management LLC now owns 152,958 shares of the company’s stock worth $379,000 after purchasing an additional 27,365 shares during the period. 67.08% of the stock is owned by institutional investors.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.